This company listing is no longer active
Medica Group Future Growth
Future criteria checks 3/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Medica Group.
Key information
19.6%
Earnings growth rate
19.6%
EPS growth rate
| Healthcare earnings growth | 20.9% |
| Revenue growth rate | 9.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 25 Apr 2023 |
Recent future growth updates
Recent updates
Medica Group (LON:MGP) Will Pay A Larger Dividend Than Last Year At £0.0188
Jun 04
Is Medica Group Plc (LON:MGP) Potentially Undervalued?
Apr 25Medica Group's (LON:MGP) Upcoming Dividend Will Be Larger Than Last Year's
Apr 06Investors Could Be Concerned With Medica Group's (LON:MGP) Returns On Capital
Jan 18Medica Group (LON:MGP) Is Increasing Its Dividend To £0.0093
Sep 30Medica Group's (LON:MGP) Shareholders Will Receive A Bigger Dividend Than Last Year
May 29Medica Group's (LON:MGP) Upcoming Dividend Will Be Larger Than Last Year's
Apr 07Medica Group's (LON:MGP) Upcoming Dividend Will Be Larger Than Last Year's
Oct 06Is It Too Late To Consider Buying Medica Group Plc (LON:MGP)?
Jul 27Medica Group Plc Just Missed Earnings - But Analysts Have Updated Their Models
May 13Why Medica Group Plc (LON:MGP) Could Be Worth Watching
Mar 09Has Medica Group (LON:MGP) Got What It Takes To Become A Multi-Bagger?
Feb 22How Much Did Medica Group's(LON:MGP) Shareholders Earn From Share Price Movements Over The Last Three Years?
Feb 08Does Medica Group's (LON:MGP) Statutory Profit Adequately Reflect Its Underlying Profit?
Jan 12
Medica Group Plc's (LON:MGP) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Dec 30An Intrinsic Calculation For Medica Group Plc (LON:MGP) Suggests It's 38% Undervalued
Dec 17Trade Alert: The Medical Director Of Medica Group Plc (LON:MGP), Stephen Davies, Has Sold Some Shares Recently
Dec 05Should You Think About Buying Medica Group Plc (LON:MGP) Now?
Dec 03We're Watching These Trends At Medica Group (LON:MGP)
Nov 21Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 103 | 14 | 16 | 18 | 3 |
| 12/31/2024 | 95 | 12 | 13 | 16 | 5 |
| 12/31/2023 | 86 | 10 | 11 | 14 | 5 |
| 12/31/2022 | 77 | 7 | 6 | 9 | N/A |
| 9/30/2022 | 74 | 7 | 8 | 10 | N/A |
| 6/30/2022 | 71 | 7 | 10 | 12 | N/A |
| 3/31/2022 | 67 | 6 | 9 | 11 | N/A |
| 12/31/2021 | 62 | 5 | 8 | 10 | N/A |
| 9/30/2021 | 54 | 4 | 5 | 7 | N/A |
| 6/30/2021 | 46 | 2 | 3 | 5 | N/A |
| 3/31/2021 | 42 | 2 | 5 | 7 | N/A |
| 12/31/2020 | 37 | 1 | 7 | 9 | N/A |
| 9/30/2020 | 39 | 3 | 8 | 10 | N/A |
| 6/30/2020 | 42 | 5 | 10 | 12 | N/A |
| 3/31/2020 | 44 | 6 | 8 | 11 | N/A |
| 12/31/2019 | 47 | 8 | 7 | 10 | N/A |
| 9/30/2019 | 44 | 8 | 6 | 9 | N/A |
| 6/30/2019 | 42 | 8 | 5 | 8 | N/A |
| 3/31/2019 | 41 | 8 | 6 | 9 | N/A |
| 12/31/2018 | 39 | 7 | 8 | 10 | N/A |
| 9/30/2018 | 38 | 7 | 8 | 10 | N/A |
| 6/30/2018 | 37 | 7 | 8 | 10 | N/A |
| 3/31/2018 | 35 | 6 | 6 | 8 | N/A |
| 12/31/2017 | 34 | 4 | 4 | 6 | N/A |
| 9/30/2017 | 32 | 3 | 4 | 5 | N/A |
| 6/30/2017 | 31 | 2 | 4 | 5 | N/A |
| 3/31/2017 | 30 | 3 | 5 | 6 | N/A |
| 12/31/2016 | 29 | 3 | 6 | 7 | N/A |
| 9/30/2016 | 27 | 3 | N/A | 7 | N/A |
| 12/31/2015 | 22 | 2 | N/A | 6 | N/A |
| 12/31/2014 | 18 | 0 | N/A | 5 | N/A |
| 12/31/2013 | 14 | -1 | N/A | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MGP's forecast earnings growth (19.6% per year) is above the savings rate (1.2%).
Earnings vs Market: MGP's earnings (19.6% per year) are forecast to grow faster than the UK market (8.7% per year).
High Growth Earnings: MGP's earnings are forecast to grow, but not significantly.
Revenue vs Market: MGP's revenue (9.8% per year) is forecast to grow faster than the UK market (4.5% per year).
High Growth Revenue: MGP's revenue (9.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MGP's Return on Equity is forecast to be high in 3 years time